Why is Vaxfab Enterprises Ltd falling/rising?

2 hours ago
share
Share Via
On 24-Dec, Vaxfab Enterprises Ltd saw its share price rise by 1.47% to ₹37.95, continuing a positive momentum driven by robust financial performance and sustained investor interest.




Consistent Outperformance Against Benchmarks


Vaxfab Enterprises Ltd has demonstrated remarkable market-beating returns over multiple time horizons, significantly outpacing the Sensex. Over the past year, the stock has surged by 289.63%, compared to the Sensex’s modest 8.84% gain. Even on a year-to-date basis, the stock’s return of 270.61% dwarfs the benchmark’s 9.30%. This exceptional performance extends to the medium term as well, with three-year returns of 103.92% against the Sensex’s 42.72%. Although the five-year return of 27.26% trails the Sensex’s 81.82%, the recent acceleration in growth highlights a strong turnaround and renewed investor interest.


Technical Strength and Rising Investor Participation


On the day in question, Vaxfab’s price movement was in line with its sector, reflecting broader market trends. The stock has been on a two-day consecutive gain streak, delivering a 3.18% return over the past week. Notably, it is trading above all key moving averages—5-day, 20-day, 50-day, 100-day, and 200-day—signalling sustained upward momentum and technical strength. This is further supported by a significant increase in delivery volume, which rose by 168.42% to 98,040 shares on 23 Dec compared to the five-day average. Such rising investor participation often indicates growing confidence and accumulation by market participants.



Patience pays off here! This Micro Cap from Fertilizers sector has delivered steady gains quarter after quarter. Now proudly part of our Reliable Performers list.



  • - New Reliable Performer

  • - Steady quarterly gains

  • - Fertilizers consistency



Discover the Steady Winner →



Strong Fundamentals Underpinning the Rally


Vaxfab Enterprises Ltd’s rise is firmly grounded in its impressive financial health and operational performance. The company maintains a low average debt-to-equity ratio of 0.09 times, reflecting prudent capital management and limited leverage risk. Its net sales have expanded at an extraordinary annual rate of 159.69%, while operating profit has grown by 60.62%, underscoring robust business growth and improving profitability.


The company has reported positive results for four consecutive quarters, with net sales in the latest six months reaching ₹69.61 crores. Return on Capital Employed (ROCE) for the half-year period stands at a high 35.14%, indicating efficient utilisation of capital to generate earnings. Furthermore, the company’s overall ROCE is an impressive 61.8, coupled with an enterprise value to capital employed ratio of 2.2, suggesting an attractive valuation relative to its peers. This valuation discount, combined with a PEG ratio of zero, highlights the stock’s potential for further appreciation given its earnings growth trajectory.


Shareholding and Market Position


The majority of Vaxfab’s shares are held by non-institutional investors, which may contribute to more dynamic trading patterns and potentially greater price volatility. Despite this, the stock has consistently outperformed the BSE500 index over the last three years, one year, and three months, reinforcing its status as a market leader within its segment.



Is Vaxfab Enterp. your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!



  • - Better alternatives suggested

  • - Cross-sector comparison

  • - Portfolio optimization tool



Find Better Alternatives →



Conclusion: Why the Stock is Rising


The upward trajectory of Vaxfab Enterprises Ltd’s share price on 24-Dec is a reflection of its strong fundamental performance, attractive valuation, and growing investor interest. The company’s exceptional sales growth, consistent profitability, and efficient capital utilisation have created a compelling investment case that has been recognised by the market. Technical indicators confirm sustained buying momentum, while rising delivery volumes suggest increased confidence among shareholders. Although the stock’s five-year returns lag the broader market, its recent surge and outperformance over shorter periods highlight a significant turnaround and renewed optimism.


Investors looking for growth opportunities within the fertilizers sector may find Vaxfab’s combination of steady quarterly gains and favourable valuation appealing. However, as with any investment, it is prudent to consider alternative options and conduct thorough analysis to ensure alignment with individual portfolio objectives.





{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News